JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Twist Bioscience Corp

Fechado

SetorSaúde

60.87 3.66

Visão Geral

Variação de preço das ações

24h

Atual

Mín

58.35

Máximo

61.73

Indicadores-chave

By Trading Economics

Rendimento

-3.4M

-31M

Vendas

4.7M

104M

Margem de lucro

-29.419

Funcionários

979

EBITDA

-3.2M

-24M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

-13.29% downside

Dividendos

By Dow Jones

Próximos Ganhos

4 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.2B

3.8B

Abertura anterior

57.21

Fecho anterior

60.87

Sentimento de Notícias

By Acuity

50%

50%

178 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Twist Bioscience Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 de abr. de 2026, 23:47 UTC

Conversa de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 de abr. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 de abr. de 2026, 22:33 UTC

Ganhos

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Executed Offtake Agreement With Ronbay

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 de abr. de 2026, 22:16 UTC

Ganhos

PLS Commences Commissioning of Midstream Demonstration Plant

23 de abr. de 2026, 22:15 UTC

Ganhos

PLS Group Reaffirms FY26 Guidance for All Metrics

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 de abr. de 2026, 22:13 UTC

Ganhos

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:11 UTC

Ganhos

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 de abr. de 2026, 22:10 UTC

Ganhos

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 de abr. de 2026, 22:09 UTC

Ganhos

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 de abr. de 2026, 22:08 UTC

Ganhos

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 de abr. de 2026, 22:04 UTC

Ganhos

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 de abr. de 2026, 21:56 UTC

Conversa de Mercado
Ganhos

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 de abr. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 de abr. de 2026, 21:27 UTC

Ganhos

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 de abr. de 2026, 21:25 UTC

Ganhos

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 de abr. de 2026, 21:24 UTC

Ganhos

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 de abr. de 2026, 21:24 UTC

Ganhos

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparação entre Pares

Variação de preço

Twist Bioscience Corp Previsão

Preço-alvo

By TipRanks

-13.29% parte inferior

Previsão para 12 meses

Média 54.8 USD  -13.29%

Máximo 58 USD

Mínimo 50 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Twist Bioscience Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

6

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

31.56 / 38.6884Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

178 / 348 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat